Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

ECM stiffness paves the way for tumor cells

An Erratum to this article was published on 08 October 2014

This article has been updated

In the mammary gland, the stiffness of extracellular matrix (ECM) collagen is thought to influence tumor progression and clinical outcome. A new mechanism orchestrated by a microRNA circuit is shown to mediate the physical effects of the microenvironment on tumor cell progression. The findings may explain how increased breast matrix stiffness is associated with poor survival and could help identify women with aggressive breast cancer (pages 360–367).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: ECM-generated mechanical force drives an miRNA circuit that promotes malignancy in preclinical models and predicts distal relapse-free survival (DRFS) in luminal breast cancer.

Katie Vicari

Change history

  • 25 August 2014

     In the version of this article initially published, the figure showed blocking arrows from HOXA9 to BRCA1 and PTEN, but these should have been regular arrows. PIP3 and AKT should have been located close to the membrane, instead of the cytoplasm. Integrin proteins should have been heterodimers rather than homodimers, and the protein β-catenin should not have had a phosphorylated residue. The errors have been corrected in the HTML and PDF versions of the article.


  1. Lu, P., Weaver, V.M. & Werb, Z. J. Cell Biol. 196, 395–406 (2012).

    Article  CAS  Google Scholar 

  2. Grady, D. New laws add a divisive component to breast screening. The New York Times. (24 October 2012).

  3. Boyd, N.F. et al. Breast Cancer Res. 13, 223–229 (2011).

    Article  Google Scholar 

  4. Cecchini, R.S. et al. Can. Prev. Res. (Phila.) 5, 1321–1329 (2012).

    Article  CAS  Google Scholar 

  5. Gierach, G.L. et al. J. Natl. Cancer Inst. 104, 1218–1227 (2012).

    Article  Google Scholar 

  6. Butcher, D.T., Alliston, T. & Weaver, V.M. Nat. Rev. Cancer 9, 108–122 (2009).

    Article  CAS  Google Scholar 

  7. Mouw, J.K. et al. Nat. Med. 20, 360–367 (2014).

    Article  CAS  Google Scholar 

  8. Sabeh, F., Shimizu-Hirota, R. & Weiss, S.J. J. Cell Biol. 185, 11–19 (2009).

    Article  CAS  Google Scholar 

  9. Friedl, P. & Wolf, K. J. Cell Biol. 188, 11–19 (2010).

    Article  CAS  Google Scholar 

  10. Lyons, T.R. et al. Nat. Med. 17, 1109–1115 (2011).

    Article  CAS  Google Scholar 

  11. Conklin, M.W. et al. Am. J. Pathol. 178, 1221–1232 (2011).

    Article  Google Scholar 

  12. Kumar, S. & Weaver, V.M. Cancer Metastasis Rev. 28, 113–127 (2009).

    Article  Google Scholar 

  13. Valastyan, S. & Weinberg, R.A. J. Cell Sci. 124, 999–1006 (2011).

    Article  CAS  Google Scholar 

  14. Gilbert, P.M. et al. J. Clin. Invest. 120, 1535–1550 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Victoria Seewaldt.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seewaldt, V. ECM stiffness paves the way for tumor cells. Nat Med 20, 332–333 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer